Offer - Urjas Oil for just ₹ 1 X
Hospicasp 70 Injection is a prescription medicine that is available as a Injection. It is typically used for the treatment of Fungal Infections, Candidal Infection. The alternative uses of Hospicasp 70 Injection have also been explained below.
The optimal dosage of Hospicasp 70 Injection is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Hospicasp 70 Injection side effects, there are can be others also. These have been listed below. Usually, these side effects of Hospicasp 70 Injection go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Hospicasp 70 Injection has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Hospicasp 70 Injection's effects on the liver, heart and kidney are discussed below in the Hospicasp 70 Injection related warnings section.
Other conditions have been mentioned below in the Hospicasp 70 Injection contraindications section.
Drug interactions for Hospicasp 70 Injection have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Hospicasp 70 Injection is considered not safe while driving, and is not addictive.
Hospicasp 70 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Hospicasp 70 Injection safe for pregnant women?
Hospicasp may have some side effects during pregnancy. Pregnant women should discontinue the use of Hospicasp, and talk to their doctor, if they notice any discomfort.
Is the use of Hospicasp 70 Injection safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Hospicasp. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Hospicasp 70 Injection on the Kidneys?
Hospicasp does not damage the kidneys.
What is the effect of Hospicasp 70 Injection on the Liver?
Hospicasp is rarely harmful for the liver.
What is the effect of Hospicasp 70 Injection on the Heart?
Using Hospicasp does not have any harmful effects on the heart.
Hospicasp 70 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Hospicasp 70 Injection unless your doctor advises you to do so -
Is this Hospicasp 70 Injection habit forming or addictive?
Hospicasp 70 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Hospicasp 70 Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Hospicasp 70 Injection only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Hospicasp 70 Injection in mental disorders is not effective.
Interaction between Food and Hospicasp 70 Injection
Taking Hospicasp 70 Injection with food is safe.
Interaction between Alcohol and Hospicasp 70 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Hospicasp 70 Injection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 289-290
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 790
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cancidas® (caspofungin acetate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Caspofungin Myx™ (caspofungin acetate)